BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 28956741)

  • 1. The Neglected Significance of Glomerular Density as a 5-year Progression Indicator for IgA Nephropathy
    Chen ZJ; Li H; Cai JF; Zhang X; Li C; Zou PM; Li MX; Chen LM; Li XM; Li XW; Wen YB
    Chin Med Sci J; 2017 Sep; 32(3):145-151. PubMed ID: 28956741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maximal glomerular diameter as a 10-year prognostic indicator for IgA nephropathy.
    Kataoka H; Ohara M; Honda K; Mochizuki T; Nitta K
    Nephrol Dial Transplant; 2011 Dec; 26(12):3937-43. PubMed ID: 21427079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time series changes in pseudo-R2 values regarding maximum glomerular diameter and the Oxford MEST-C score in patients with IgA nephropathy: A long-term follow-up study.
    Kataoka H; Ohara M; Suzuki T; Inoue T; Akanuma T; Kawachi K; Manabe S; Ushio Y; Kawasoe K; Akihisa T; Sato M; Iwasa N; Sawara Y; Honda K; Mochizuki T; Tsuchiya K; Nitta K
    PLoS One; 2020; 15(5):e0232885. PubMed ID: 32379841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological Features to Predict Progression of IgA Nephropathy with Mild Proteinuria.
    Chen D; Liu J; Duan S; Chen P; Tang L; Zhang L; Feng Z; Cai G; Wu J; Chen X
    Kidney Blood Press Res; 2018; 43(2):318-328. PubMed ID: 29529608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for progression in children and young adults with IgA nephropathy: an analysis of 261 cases from the VALIGA European cohort.
    Coppo R; Lofaro D; Camilla RR; Bellur S; Cattran D; Cook HT; Roberts IS; Peruzzi L; Amore A; Emma F; Fuiano L; Berg U; Topaloglu R; Bilginer Y; Gesualdo L; Polci R; Mizerska-Wasiak M; Caliskan Y; Lundberg S; Cancarini G; Geddes C; Wetzels J; Wiecek A; Durlik M; Cusinato S; Rollino C; Maggio M; Praga M; K Smerud H; Tesar V; Maixnerova D; Barratt J; Papalia T; Bonofiglio R; Mazzucco G; Giannakakis C; Soderberg M; Orhan D; Di Palma AM; Maldyk J; Ozluk Y; Sudelin B; Tardanico R; Kipgen D; Steenbergen E; Karkoszka H; Perkowska-Ptasinska A; Ferrario F; Gutierrez E; Honsova E
    Pediatr Nephrol; 2017 Jan; 32(1):139-150. PubMed ID: 27557557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of Progression in IgA Nephropathy in Childhood.
    Mizerska-Wasiak M; Małdyk J; Turczyn A; Cichoń-Kawa K; Rybi-Szumińska A; Wasilewska A; Bieniaś B; Zajączkowska M; Miklaszewska M; Pietrzyk J; Demkow U; Roszkowska-Blaim M; Pańczyk-Tomaszewska M
    Adv Exp Med Biol; 2017; 955():65-73. PubMed ID: 27718216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-Term Outcomes in IgA Nephropathy.
    Pitcher D; Braddon F; Hendry B; Mercer A; Osmaston K; Saleem MA; Steenkamp R; Wong K; Turner AN; Wang K; Gale DP; Barratt J
    Clin J Am Soc Nephrol; 2023 Jun; 18(6):727-738. PubMed ID: 37055195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of angiotensin-converting enzyme gene polymorphism on the progression of immunoglobulin A nephropathy in Malaysian patients.
    Draman CR; Kong NC; Gafor AH; Rahman AF; Zainuddin S; Mustaffa WM; Radzi AM; Shamsul AS
    Singapore Med J; 2008 Nov; 49(11):924-9. PubMed ID: 19037561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of glucocorticoids alone and combined with cyclosporine a in patients with IgA nephropathy: a prospective randomized controlled trial.
    Liu H; Xu X; Fang Y; Ji J; Zhang X; Yuan M; Liu C; Ding X
    Intern Med; 2014; 53(7):675-81. PubMed ID: 24694475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin D deficiency may predict a poorer outcome of IgA nephropathy.
    Li XH; Huang XP; Pan L; Wang CY; Qin J; Nong FW; Luo YZ; Wu Y; Huang YM; Peng X; Yang ZH; Liao YH
    BMC Nephrol; 2016 Nov; 17(1):164. PubMed ID: 27806690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review of cases of IgA nephropathy.
    World MJ
    J R Army Med Corps; 2013 Jun; 159(2):90-3. PubMed ID: 23720589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term renal survival and related risk factors in patients with IgA nephropathy: results from a cohort of 1155 cases in a Chinese adult population.
    Le W; Liang S; Hu Y; Deng K; Bao H; Zeng C; Liu Z
    Nephrol Dial Transplant; 2012 Apr; 27(4):1479-85. PubMed ID: 21965586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of some pathophysiological mechanisms of the CKD progression theory and outcome prediction in IgA nephropathy.
    Bazzi C; Rizza V; Casellato D; Stivali G; Rachele G; Napodano P; Olivieri G; Gallieni M; D'Amico G
    J Nephrol; 2012; 25(5):810-8. PubMed ID: 22252844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implication of urinary complement factor H in the progression of immunoglobulin A nephropathy.
    Liu M; Chen Y; Zhou J; Liu Y; Wang F; Shi S; Zhao Y; Wang S; Liu L; Lv J; Zhang H; Zhao M
    PLoS One; 2015; 10(6):e0126812. PubMed ID: 26035554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesangial C4d deposition may predict progression of kidney disease in pediatric patients with IgA nephropathy.
    Fabiano RCG; de Almeida Araújo S; Bambirra EA; Oliveira EA; Simões E Silva AC; Pinheiro SVB
    Pediatr Nephrol; 2017 Jul; 32(7):1211-1220. PubMed ID: 28233100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunosuppressive therapy in patients with IgA nephropathy.
    Peters HP; van den Brand JA; Berger SP; Wetzels JF
    Neth J Med; 2015 Jul; 73(6):284-9. PubMed ID: 26228193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of oral steroids with tonsillectomy plus steroid pulse therapy in patients with IgA nephropathy.
    Hoshino Y; Moriyama T; Uchida K; Tsuchiya K; Nitta K
    Clin Exp Nephrol; 2017 Aug; 21(4):617-623. PubMed ID: 27549901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Addition of eGFR and Age Improves the Prognostic Absolute Renal Risk-Model in 1,134 Norwegian Patients with IgA Nephropathy.
    Knoop T; Vågane AM; Vikse BE; Svarstad E; Magnúsdóttir BT; Leh S; Varberg Reisæter A; Bjørneklett R
    Am J Nephrol; 2015; 41(3):210-9. PubMed ID: 25872002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The precise long-term outcomes of adult IgA nephropathy by mail questionnaires: Better renal survival compared to earlier cohort studies.
    Imai E; Usui J; Kaneko S; Kawamura T; Suka M; Yamagata K
    PLoS One; 2020; 15(5):e0233186. PubMed ID: 32413080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced pre-pregnancy proteinuria is associated with improving postnatal maternal renal outcomes in IgA nephropathy women.
    Oh HJ; Han SH; Yoo DE; Kim SJ; Park JT; Kim JK; Yoo TH; Kang SW; Choi KH
    Clin Nephrol; 2011 Dec; 76(6):447-54. PubMed ID: 22105447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.